V027-4850 Screening compound: N-[2-(morpholin-4-yl)ethyl]-3-{2-phenyl-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridin-3-yl}propanamide

V027-4850 Screening compound: N-[2-(morpholin-4-yl)ethyl]-3-{2-phenyl-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridin-3-yl}propanamide
V027-4850 Screening compound: N-[2-(morpholin-4-yl)ethyl]-3-{2-phenyl-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridin-3-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V027-4850
N-[2-(morpholin-4-yl)ethyl]-3-{2-phenyl-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridin-3-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V027-4850

Molecular Formula

C29H29F3N4O2 (C29 H29 F3 N4 O2)

Compound Name

N-[2-(morpholin-4-yl)ethyl]-3-{2-phenyl-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridin-3-yl}propanamide

IUPAC name

N-[2-(morpholin-4-yl)ethyl]-3-{2-phenyl-6-[3-(trifluoromethyl)phenyl]imidazo[12-a]pyridin-3-yl}propanamide

SMILES

O=C(CCc1c(-c2ccccc2)nc(cc2)n1cc2-c1cccc(C(F)(F)F)c1)NCCN1CCOCC1

InChI

InChI=1S/C29H29F3N4O2/c30-29(31,32)24-8-4-7-22(19-24)23-9-11-26-34-28(21-5-2-1-3-6-21)25(36(26)20-23)10-12-27(37)33-13-14-35-15-17-38-18-16-35/h1-9,11,19-20H,10,12-18H2,(H,33,37)

InChI Key

VSUYXYCQAZDDSE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20494507

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

522.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.287

Distribution Coefficient, logD

4.211

Water Solubility, LogSw

-4.29

Polar Surface Area

44.159

Acid Dissociation Constant (pKa)

13.52

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

V027-4850 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V027-4850 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V027-4850?
Check Price and Availability of V027-4850, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V027-4850 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V027-4850
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V027-4850
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V027-4850 available by request